This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Alan Eric Fischer: Innovator in Enantiomerically Enriched Compounds
Introduction
Alan Eric Fischer is a notable inventor based in Biberstein, Switzerland. He has made significant contributions to the field of chemistry, particularly in the preparation of enantiomerically enriched compounds. His work is essential for developing pharmacological solutions for insulin resistance syndrome.
Latest Patents
Fischer holds a patent for a process that focuses on the preparation of enantiomerically enriched intermediates. This invention is particularly relevant for creating the (S)-enantiomer of certain 2-ethoxy-3-(4-hydroxyphenyl)propanoic acids and their derivatives. The novel resolution methods he developed are crucial for advancing pharmaceutical applications.
Career Highlights
Alan Eric Fischer is associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on innovative solutions that address critical health issues. With a patent portfolio that includes 1 patent, Fischer continues to contribute to advancements in the pharmaceutical industry.
Collaborations
Fischer has collaborated with esteemed colleagues such as Panagiotis Ioannidis and Magnus Larsson. These partnerships enhance the research and development efforts within his field, fostering innovation and progress.
Conclusion
Alan Eric Fischer's work in the preparation of enantiomerically enriched compounds showcases his dedication to advancing pharmaceutical science. His contributions are vital for addressing health challenges, particularly in relation to insulin resistance syndrome.